Lanvin Group Holdings Limited (LANV)

NYSE: LANV · Real-Time Price · USD
2.240
+0.050 (2.28%)
Jul 3, 2025, 1:00 PM - Market closed
2.28%
Market Cap 262.80M
Revenue (ttm) 340.21M
Net Income (ttm) -171.09M
Shares Out 117.32M
EPS (ttm) -1.46
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 20,486
Open 2.150
Previous Close 2.190
Day's Range 2.100 - 2.320
52-Week Range 0.912 - 2.690
Beta -0.25
Analysts n/a
Price Target n/a
Earnings Date Aug 25, 2025

About LANV

Lanvin Group Holdings Limited operates as a couture house for men and women in Europe, the Middle East, Africa, North America, Greater China, and other Asian countries. It operates through Lanvin, Wolford, Caruso, St. John, Sergio Rossi, and Other and Holding Companies segments. The company offers ready-to-wear products comprising bodysuits, tops, trousers, dresses, skirts, jumpsuits, jackets, and cardigans; made-to-measure products; footwear, including sneakers; leather goods; costume jewelry; small accessories, such as scarves, hats, belts, t... [Read more]

Industry Luxury Goods
Founded 2015
Employees 2,406
Stock Exchange NYSE
Ticker Symbol LANV
Full Company Profile

Financial Performance

In 2024, Lanvin Group's revenue was 328.61 million, a decrease of -22.89% compared to the previous year's 426.18 million. Losses were -165.26 million, 27.8% more than in 2023.

Financial numbers in EUR Financial Statements

News

Lanvin Group Holdings Limited (LANV) Q4 2024 Earnings Call Transcript

Lanvin Group Holdings Limited (NYSE:LANV) Q4 2024 Earnings Conference Call April 30, 2025 8:00 AM ET Company Participants David Chan - Executive President & Chief Financial Officer Andy Lew - Executi...

2 months ago - Seeking Alpha

Lanvin Group Demonstrates Strategic Resilience in Challenging Luxury Market, Lays Foundation for Future Growth

The Group reported revenue of €329 million in FY2024, down 23% over FY2023, reflecting a transitional year marked by creative evolution and strategic realignment amid market headwinds Gross profit mar...

2 months ago - PRNewsWire

Lanvin Group to Report 2024 Full-Year Audited Results on April 30, 2025

NEW YORK , April 18, 2025 /PRNewswire/ -- Lanvin Group (NYSE: LANV, the "Group"), a global luxury fashion group, will release its audited results for the full-year 2024 on Wednesday, April 30, 2025. O...

2 months ago - PRNewsWire

PharmaEssentia Highlights Availability of BESREMi® (ropeginterferon alfa-2b-njft) for Patients Affected by Pegasys® (peginterferon alfa-2a) Drug Shortage

BURLINGTON, Mass.--(BUSINESS WIRE)--PharmaEssentia USA Corporation, a subsidiary of PharmaEssentia Corporation (TWSE: 6446), a global biopharmaceutical innovator based in Taiwan leveraging deep expert...

4 months ago - Business Wire

Lanvin Group Holdings Limited (LANV) 2024 Sales/Trading Statement Call Transcript

Lanvin Group Holdings Limited (NYSE:LANV) 2024 Sales/Trading Statement Call February 28, 2025 8:00 AM ET Company Participants David Chan - Executive President and Chief Financial Officer Andy Lew - E...

4 months ago - Seeking Alpha

Lanvin Group Prioritizes Creative Renewal and Operational Agility Amid Evolving Luxury Landscape

Revenue of €328 million in FY2024, a 23% decrease over FY2023, reflecting a transitional year marked by creative evolution and strategic realignment amid market headwinds St. John and Caruso demonstra...

4 months ago - PRNewsWire

Lanvin Group to Report 2024 Full-Year Preliminary Revenues on February 28, 2025

NEW YORK , Feb. 17, 2025 /PRNewswire/ -- Lanvin Group (NYSE: LANV, the "Group"), a global luxury fashion group, today opened registration for its 2024 revenue results conference call. The Group will r...

4 months ago - PRNewsWire

Lanvin Group Announces Leadership and Board Changes to Accelerate Growth and Strategic Initiatives

NEW YORK , Jan. 16, 2025 /PRNewswire/ -- Lanvin Group (NYSE: LANV) (the "Company") today announced key leadership and board changes designed to strengthen its position in the luxury fashion industry a...

6 months ago - PRNewsWire

PharmaEssentia Announces Positive Topline Phase 3 Data from SURPASS-ET Study Evaluating Ropeginterferon Alfa-2b-njft (P1101) for Essential Thrombocythemia

BURLINGTON, Mass.--(BUSINESS WIRE)--PharmaEssentia Corporation (TWSE: 6446), a global biopharmaceutical innovator based in Taiwan leveraging deep expertise and proven scientific principles to deliver ...

6 months ago - Business Wire

Lanvin Group Holdings Limited to Hold Annual General Meeting on December 11, 2024

NEW YORK , Nov. 19, 2024 /PRNewswire/ -- Lanvin Group Holdings Limited (NYSE: LANV, the "Company" or "Lanvin Group"), a global luxury fashion group, today announced that it will hold its annual genera...

8 months ago - PRNewsWire

PharmaEssentia Announces Licensing Agreement with FORUS Therapeutics to Commercialize BESREMi® (ropeginterferon alfa-2b-njft) in Canada

BURLINGTON, Mass.--(BUSINESS WIRE)--PharmaEssentia Corporation (TWSE: 6446), a global biopharmaceutical innovator based in Taiwan leveraging deep expertise and proven scientific principles to deliver ...

10 months ago - Business Wire

Lanvin Group Holdings Limited (LANV) Q2 2024 Earnings Call Transcript

Lanvin Group Holdings Limited (NYSE:LANV) Q2 2024 Earnings Conference Call August 26, 2024 8:00 AM ET Company Participants Eric Chan - CEO David Chan - Executive President and CFO Conference Call Par...

11 months ago - Seeking Alpha

Lanvin Group Posts Revenue of €171 million in H1 2024

Global Challenges Impact First-Half Results Group Revenue was €171 million for H1 2024, a 20% decrease over H1 2023 Group Gross profit margin remained steady, declining just 1% to 57.5%, and Lanvin, S...

11 months ago - PRNewsWire

SERGIO ROSSI APPOINTS PAUL ANDREW CREATIVE DIRECTOR

MILAN, July 24, 2024 /PRNewswire/ -- Lanvin Group (NYSE: LANV, the "Group"), a global luxury fashion group, announced today that Sergio Rossi, an Italian luxury footwear brand, has appointed Paul Andr...

1 year ago - PRNewsWire

LANVIN APPOINTS PETER COPPING ARTISTIC DIRECTOR

NEW YORK , June 27, 2024 /PRNewswire/ -- Lanvin Group (NYSE: LANV, the "Group"), a global luxury fashion group, announced today that Lanvin, Lanvin Group's flagship brand and the oldest continually op...

1 year ago - PRNewsWire

Regis Rimbert Named CEO of Wolford AG

NEW YORK , June 13, 2024 /PRNewswire/ -- Lanvin Group (NYSE: LANV, the "Group"), a global luxury fashion group, announced today that Regis Rimbert has been appointed as CEO of Wolford AG by the Wolfor...

1 year ago - PRNewsWire

ees Europe: Battery Storage – Powerbanks for the Energy Transition

MUNICH & PFORZHEIM, Germany--(BUSINESS WIRE)--Battery storage is booming. According to a study by Frontier Economics, the volume of grid-connected storage in Germany alone could increase to 60 gigawat...

1 year ago - Business Wire

BESREMi® (Ropeginterferon alfa-2B) Shows Greatest Benefit Among Cytoreductive Therapies in Lowering Symptomatic Burden of Polycythemia Vera (PV): Real-World Analysis Published at ASCO

BURLINGTON, Mass.--(BUSINESS WIRE)--PharmaEssentia USA Corporation, a subsidiary of PharmaEssentia Corporation (TWSE: 6446), a global biopharmaceutical innovator based in Taiwan leveraging deep expert...

1 year ago - Business Wire

Lanvin Group Holdings Limited (LANV) Q4 2023 Earnings Call Transcript

Lanvin Group Holdings Limited (NYSE:LANV) Q4 2023 Earnings Conference Call April 30, 2024 8:00 AM ET Company Participants Eric Chan - Chief Executive Officer David Chan - Executive President & Chief ...

1 year ago - Seeking Alpha

Lanvin Group Shows Resiliency in Sales and On-Track Margin Improvement in 2023

Revenue Continues Year-o ver -Year Growth Trend Revenue of €426 million for FY2023, a 1% increase over FY2022 despite macroeconomic headwinds Continued margin improvement with Group gross profit margi...

1 year ago - PRNewsWire

Lanvin Group to Report 2023 Full-Year Audited Results on April 30, 2024

NEW YORK , April 22, 2024 /PRNewswire/ -- Lanvin Group (NYSE: LANV, the "Group"), a global luxury fashion group, will release its audited results for the full-year 2023 on Tuesday, April 30, 2024. On ...

1 year ago - PRNewsWire

Analyses Find Patients With Polycythemia Vera (PV) Treated With BESREMi® (ropeginterferon alfa-2b) Had Increased Probability of Achieving Complete Hematologic Response

BURLINGTON, Mass.--(BUSINESS WIRE)--PharmaEssentia USA Corporation, a subsidiary of PharmaEssentia Corporation (TWSE: 6446), a global biopharmaceutical innovator based in Taiwan leveraging deep expert...

1 year ago - Business Wire

Lanvin Group Holdings Limited (LANV) 2023 Sales/ Trading Statement Call Transcript

Lanvin Group Holdings Limited (LANV) 2023 Sales/ Trading Statement Call Transcript

1 year ago - Seeking Alpha

Lanvin Group Resiliency was Key in 2023, Preliminary Revenues Up 1% Year-on-Year

Revenue of €426 million for FY2023, a 1% increase over FY 2022 Despite challenging conditions, Lanvin Group grew revenue by 8% in APAC Resiliency through creative transition at Lanvin brand helped imp...

1 year ago - PRNewsWire

Lanvin Group to Report 2023 Full-Year Preliminary Revenues on February 21, 2024

NEW YORK , Feb. 6, 2024 /PRNewswire/ -- Lanvin Group (NYSE: LANV, the "Group"), a global luxury fashion group, today opened registration for its 2023 revenue results conference call. The Group will re...

1 year ago - PRNewsWire